Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The centerpiece of the ...

“We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental ...

In the final part of his interview with Pharmaceutical Commerce, Anthony “TJ” Rizzo, chief commercial officer of Cold Chain ...

Annex 21 is sometimes viewed as a narrow regulatory annex, but its implications are much broader. It sits at the intersection ...

The number of approved advanced therapies may triple by 2030. The majority of health system survey respondents agreed (63%) ...

Anthony “TJ” Rizzo explains what makes an effective supply chain partnership, and how tech can be deployed alongside human ...

Network “intelligence” depends on flexible modal strategies, diversified gateways, and pre-qualified alternative lanes, ...

In today’s Pharma Pulse, Walgreens reshapes pharmacist roles, pharmacies expand injectable access, GoodRx and Eli Lilly ...

Ahead of his presentation at LogiPharma 2026, Anthony “TJ” Rizzo discusses how automation and real-time monitoring can be ...

Richard Harrop shares how pharma can strike a balance between performance, sustainability, and resilience in packaging design ...

In the second part of his interview with Pharmaceutical Commerce, Roel van den Akker, Deals partner at PwC, discusses the ...